| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |